Angiogenesis and endothelial cell repair in renal disease and allograft rejection

Journal of the American Society of Nephrology

Volumn 17, Issue 4, 2006, Pages 932-942

  Reinders, Marlies E J ^a,b,c   Rabelink, Ton J ^c   Briscoe, David M ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; BONE MARROW; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROTECTION; CELL REGENERATION; CELL TRANSFER; CHRONIC KIDNEY FAILURE; ENDOTHELIUM CELL; ENDOTHELIUM STEM CELL; GRAFT REJECTION; HUMAN; HYPOXIA; INFLAMMATION; KIDNEY BLOOD VESSEL; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY INTERSTITIUM; LEUKOCYTE MIGRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SENESCENCE; STEM CELL; TISSUE REPAIR; VASCULAR ENDOTHELIUM;

EID: 33645469671     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005121250     Document Type: Review

References (121)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995
2. Ferrara N: Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 55: 15-35; discussion 35-36, 2000
3. Cotran RS: Inflammation and repair. In: Pathologic Basis of Disease, edited by Cotran RS, Kumar V, Robbins SL, Philadelphia, WB Saunders, 1994, pp 51-92
4. Polverini PJ: Role of the macrophage in angiogenesis-dependent diseases. EXS 79: 11-28, 1997
5. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo KM, Gillies S, Javaherian K, Folkman J: Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A 100: 4736-4741, 2003
6. Nykanen AI, Krebs R, Saaristo A, Turunen P, Alitalo K, Yla-Herttuala S, Koskinen PK, Lemstrom KB: Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation 107: 1308-1314, 2003
7. Lemstrom KB, Krebs R, Nykanen AI, Tikkanen JM, Sihvola RK, Aaltola EM, Hayry PJ, Wood J, Alitalo K, Yla-Herttuala S, Koskinen PK: Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis. Circulation 105: 2524-2530, 2002
8. Denton MD, Magee C, Melter M, Dharnidharka VR, Sayegh MH, Briscoe DM: TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy. Transplantation 78: 1218-1221, 2004
9. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ: Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 13: 806-816, 2002
10. Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H: Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. Diabetes 54: 2891-2903, 2005
11. Carmeliet P: Manipulating angiogenesis in medicine. J Intern Med 255: 538-561, 2004
12. Libby P, Zhao DX: Allograft arteriosclerosis and immune-driven angiogenesis. Circulation 107: 1237-1239, 2003
13. Adamis AP, Aiello LP, D'Amato RA: Angiogenesis and ophthalmic disease. Angiogenesis 3: 9-14, 1999
14. Kang DH, Nakagawa T, Feng L, Johnson RJ: Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol 161: 239-248, 2002
15. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12: 1434-1447, 2001
16. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12: 1448-1457, 2001
17. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M: Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 361: 206-210, 2003
18. Woywodt A, Schroeder M, Mengel M, Schwarz A, Gwinner W, Haller H, Haubitz M: Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage. Hypertension 41: 720-723, 2003
19. Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, Clancy RM, Haubitz M, Hebbel RP, Lip GY, Mancuso P, Sampol J, Solovey A, Dignat-George F: Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 93: 228-235, 2005
20. Rafii S, Lyden D: Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9: 702-712, 2003
21. Sidky YA, Auerbach R: Lymphocyte-induced angiogenesis: A quantitative and sensitive assay of the graft-vs.-host reaction. J Exp Med 141: 1084-1100, 1975
22. Auerbach R, Sidky YA: Nature of the stimulus leading to lymphocyte-induced angiogenesis. J Immunol 123: 751-754, 1979
23. Libby P, Pober JS: Chronic rejection. Immunity 14: 387-397, 2001
24. Reinders ME, Briscoe DM: Angiogenesis and allograft rejection. Graft 5: 96-101, 2002
25. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N: Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329: 630-632, 1987
26. Leibovich SJ, Wiseman DM: Macrophages, wound repair and angiogenesis. Prog Clin Biol Res 266: 131-145, 1988
27. Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ: Impaired angiogenesis in the aging kidney: Vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 37: 601-611, 2001
28. Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y, Yamanaka N: Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 159: 599-608, 2001
29. Iruela-Arispe L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ: Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol 147: 1715-1727, 1995
30. Reinders ME, Sho M, Izawa A, Wang P, Mukhopadhyay D, Koss KE, Geehan CS, Luster AD, Sayegh MH, Briscoe DM: Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 112: 1655-1665, 2003
31. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007, 2005
32. Rosenzweig A: Circulating endothelial progenitors-Cells as biomarkers. N Engl J Med 353: 1055-1057, 2005
33. Koc M, Richards HB, Bihorac A, Ross EA, Schold JD, Segal MS: Circulating endothelial cells are associated with future vascular events in hemodialysis patients. Kidney Int 67: 1078-1083, 2005
34. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370-1376, 2003
35. Ackah E, Yu J, Zoellner S, Iwakiri Y, Skurk C, Shibata R, Ouchi N, Easton RM, Galasso G, Birnbaum MJ, Walsh K, Sessa WC: Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest 115: 2119-2127, 2005
36. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997
37. Wu X, Rabkin-Aikawa E, Guleserian KJ, Perry TE, Masuda Y, Sutherland FW, Schoen FJ, Mayer JE Jr, Bischoff J: Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol 287: H480-H487, 2004
38. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schafer B, Hossfeld DK, Fiedler W: In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95: 3106-3112, 2000
39. Romagnani P, Annunziato F, Liotta F, Lazzeri E, Mazzinghi B, Frosali F, Cosmi L, Maggi L, Lasagni L, Scheffold A, Kruger M, Dimmeler S, Marra F, Gensini G, Maggi E, Romagnani S: CD14+CD34 low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 97: 314-322, 2005
40. Solovey AN, Gui L, Chang L, Enenstein J, Browne PV, Hebbel RP: Identification and functional assessment of endothelial P1H12. J Lab Clin Med 138: 322-331, 2001
41. Rabelink TJ, de Boer HC, de Koning EJ, van Zonneveld AJ: Endothelial progenitor cells: More than an inflammatory response? Arteriosder Thromb Vasc Biol 24: 834-838, 2004
42. Rafii S, Meeus S, Dias S, Hattori K, Heissig B, Shmelkov S, Rafii D, Lyden D: Contribution of marrow-derived progenitors to vascular and cardiac regeneration. Semin Cell Dev Biol 13: 61-67, 2002
43. Lapidot T, Petit I: Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 30: 973-981, 2002
44. Norol F, Merlet P, Isnard R, Sebillon P, Bonnet N, Cailliot C, Carrion C, Ribeiro M, Charlotte F, Pradeau P, Mayol JF, Peinnequin A, Drouet M, Safsafi K, Vernant JP, Herodin F: Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood 102: 4361-4368, 2003
45. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P: Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705, 2001
46. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P: Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98: 10344-10349, 2001
47. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P: Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 938: 221-229; discussion 229-230, 2001
48. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T: Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438, 1999
49. Polverini PJ, Cotran PS, Gimbrone MA Jr, Unanue ER: Activated macrophages induce vascular proliferation. Nature 269: 804-806, 1977
50. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch AE: Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci U S A 91: 4190-4194, 1994
51. Giraudo E, Primo L, Audero E, Gerber HP, Koolwijk P, Soker S, Klagsbrun M, Ferrara N, Bussolino F: Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J Biol Chem 273: 22128-22135, 1998
52. Reinders ME, Sho M, Robertson SW, Geehan CS, Briscoe DM: Proangiogenic function of CD40 ligand-CD40 interactions. J Immunol 171: 1534-1541, 2003
53. Melter M, Reinders ME, Sho M, Pal S, Geehan C, Denton MD, Mukhopadhyay D, Briscoe DM: Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96: 3801-3808, 2000
54. Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ: Transforming growth factor-beta (TGFbeta) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 157: 793-800, 1988
55. Koch AE, Polverini PJ, Leibovich SJ: Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum 29: 471-479, 1986
56. Koch AE, Polverini PJ, Leibovich SJ: Induction of neovascularization by activated human monocytes. J Leukoc Biol 39: 233-238, 1986
57. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsbrun M: Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Res 55: 4140-4145, 1995
58. Klagsbrun M, D'Amore PA: Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 7: 259-270, 1996
59. Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM, Dvorak HF: Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine. EXS 79: 233-269, 1997
60. Moulton KS, Melder RJ, Dharnidharka VR, Hardin-Young J, Jain RK, Briscoe DM: Angiogenesis in the huPBL-SCID model of human transplant rejection. Transplantation 67: 1626-1631, 1999
61. Melder RJ, Yuan J, Munn LL, Jain RK: Erythrocytes enhance lymphocyte rolling and arrest in vivo. Microvasc Res 59: 316-322, 2000
62. Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK: Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111: 1-6, 1998
63. Melder RJ, Salehi HA, Jain RK: Interaction of activated natural killer cells with normal and tumor vessels in cranial windows in mice. Microvasc Res 50: 35-44, 1995
64. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK: During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 2: 992-997, 1996
65. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY: Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276: 7614-7620, 2001
66. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D: Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336-3343, 1996
67. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039, 1995
68. Boulday G, Haskova Z, Reinders ME, Pal S, Briscoe DM: Vascular endothelial growth factor-induced signaling pathways in endothelial cells that mediate over-expression of the chemokine IP-10 in vitro and in vivo. J Immunol 2006, in press
69. Woywodt A, Schroeder M, Gwinner W, Mengel M, Jaeger M, Schwarz A, Haller H, Haubitz M: Elevated numbers of circulating endothelial cells in renal transplant recipients. Transplantation 76: 1-4, 2003
70. Kurz DJ, Decary S, Hong Y, Trivier E, Akhmedov A, Erusalimsky JD: Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci 117: 2417-2426, 2004
71. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S: Endothelial progenitor cells: New hope for a broken heart. Circulation 107: 3093-3100, 2003
72. Ferrero E, Bondanza A, Leone BE, Manici S, Poggi A, Zocchi MR: CD14+ CD34+ peripheral blood mononuclear cells migrate across endothelium and give rise to immunostimulatory dendritic cells. J Immunol 160: 2675-2683, 1998
73. Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA: Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282: 480-483, 1998
74. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999
75. Ohashi R, Kitamura H, Yamanaka N: Peri tubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol 11: 47-56, 2000
76. Ohashi R, Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N: Peritubular capillary regression during the progression of experimental obstructive nephropathy. J Am Soc Nephrol 13: 1795-1805, 2002
77. Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ: Tubulointerstitial disease in aging: Evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol 9: 231-242, 1998
78. Shulman K, Rosen S, Tognazzi K, Manseau EJ, Brown LF: Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 7: 661-666, 1996
79. Eremina V, Quaggin SE: The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens 13: 9-15, 2004
80. Brown LF, Berse B, Tognazzi K, Manseau EJ, Van de Water L, Senger DR, Dvorak HF, Rosen S: Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 42: 1457-1461, 1992
81. Haltia A, Solin ML, Jalanko H, Holmberg C, Miettinen A, Holthofer H: Mechanisms of proteinuria: Vascular permeability factor in congenital nephrotic syndrome of the Finnish type. Pediatr Res 40: 652-657, 1996
82. Mattot V, Moons L, Lupu F, Chernavvsky D, Gomez RA, Collen D, Carmeliet P: Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. J Am Soc Nephrol 13: 1548-1560, 2002
83. Kitamoto Y, Tokunaga H, Miyamoto K, Tomita K: VEGF is an essential molecule for glomerular structuring. Nephrol Dial Transplant 17[Suppl 9]: 25-27, 2002
84. Tufro A, Norwood VF, Carey RM, Gomez RA: Vascular endothelial growth factor induces nephrogenesis and vasculogenesis. J Am Soc Nephrol 10: 2125-2134, 1999
85. Luttun A, Carmeliet P: Soluble VEGF receptor Flt1: The elusive preeclampsia factor discovered? J Clin Invest 111: 600-602, 2003
86. Ly J, Alexander M, Quaggin SE: A podocentric view of nephrology. Curr Opin Nephrol Hypertens 13: 299-305, 2004
87. Ostendorf T, Kunter U, Eitner F, Loos A, Regele H, Kerjaschki D, Henninger DD, Janjic N, Floege J: VEGF(165) mediates glomerular endothelial repair. J Clin Invest 104: 913-923, 1999
88. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R: Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278: 12605-12608, 2003
89. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658, 2003
90. Nangaku M, Alpers CE, Pippin J, Shankland SJ, Adler S, Kurokawa K, Couser WG, Johnson RJ: A new model of renal microvascular endothelial injury. Kidney Int 52: 182-194, 1997
91. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972, 1999
92. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, Silver M, Li T, Isner JM, Asahara T: Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105: 732-738, 2002
93. Uchimura H, Marumo T, Takase O, Kawachi H, Shimizu F, Hayashi M, Saruta T, Hishikawa K, Fujita T: Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis. J Am Soc Nephrol 16: 997-1004, 2005
94. Ikarashi K, Li B, Suwa M, Kawamura K, Morioka T, Yao J, Khan F, Uchiyama M, Oite T: Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells. Kidney Int 67: 1925-1933, 2005
95. Rookmaaker MB, Smits AM, Tolboom H, Van't Wout K, Martens AC, Goldschmeding R, Joles JA, Van Zonneveld AJ, Grone HJ, Rabelink TJ, Verhaar MC: Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol 163: 553-562, 2003
96. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, Quaggin SE: Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716, 2003
97. de Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH: Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12: 993-1000, 2001
98. Yamamoto Y, Maeshima Y, Kitayama H, Kitamura S, Takazawa Y, Sugiyama H, Yamasaki Y, Makino H: Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 53: 1831-1840, 2004
99. Waldman WJ, Knight DA, Huang EH: An in vitro model of T cell activation by autologous cytomegalovirus (CMV)-infected human adult endothelial cells: Contribution of CMV-enhanced endothelial ICAM-1. J Immunol 160: 3143-3151, 1998
100. Melter M, McMahon G, Fang J, Ganz P, Briscoe DM: Current understanding of chemokine involvement in allograft transplantation. Pediatr Transplant 3: 10-21, 1999
101. Reinders ME, Fang JC, Wong W, Ganz P, Briscoe DM: Expression patterns of vascular endothelial growth factor in human cardiac allografts: Association with rejection. Transplantation 76: 224-230, 2003
102. Pober JS: Is host endothelium a silver lining for allografts? Lancet 357: 2-3, 2001
103. Bolli R: Regeneration of the human heart-No chimera? N Engl J Med 346: 55-56, 2002
104. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, Anversa P: Chimerism of the transplanted heart. N Engl J Med 346: 5-15, 2002
105. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, van Es LA, Bruijn JA, van Krieken JH: Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 357: 33-37, 2001
106. Grimm PC, Nickerson P, Jeffery J, Savani RC, Gough J, McKenna RM, Stern E, Rush DN: Neointimal and rubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 345: 93-97, 2001
107. Valujskikh A, Lantz O, Celli S, Matzinger P, Heeger PS: Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat Immunol 3: 844-851, 2002
108. Sayegh MH, Carpenter CB: Role of indirect allorecognition in allograft rejection. Int Rev Immunol 13: 221-229, 1996
109. Briscoe DM, Yeung AC, Schoen FJ, Allred EN, Stavrakis G, Ganz P, Cotran RS, Pober JS, Schoen EL: Predictive value of inducible endothelial cell adhesion molecule expression for acute rejection of human cardiac allografts. Transplantation 59: 204-211, 1995
110. Denton MD, Davis SF, Baum MA, Melter M, Reinders ME, Exeni A, Samsonov DV, Fang J, Ganz P, Briscoe DM: The role of the graft endothelium in transplant rejection: Evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection. Pediatr Transplant 4: 252-260, 2000
111. Melter M, Exeni A, Reinders ME, Fang JC, McMahon G, Ganz P, Hancock WW, Briscoe DM: Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 104: 2558-2564, 2001
112. Atkinson C, Southwood M, Pitman R, Phillpotts C, Wallwork J, Goddard M: Angiogenesis occurs within the intimal proliferation that characterizes transplant coronary artery vasculopathy. J Heart Lung Transplant 24: 551-558, 2005
113. Tanaka H, Sukhova GK, Libby P: Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb 14: 734-745, 1994
114. Adams DH, Russell ME, Hancock WW, Sayegh MH, Wyner LR, Karnovsky MJ: Chronic rejection in experimental cardiac transplantation: Studies in the Lewis-F344 model. Immunol Rev 134: 5-19, 1993
115. Chandraker A, Russell ME, Glysing-Jensen T, Willett TA, Sayegh MH: T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: Effects of cyclosporine and donor antigen. Transplantation 63: 1053-1058, 1997
116. Maiese K, Li F, Chong ZZ: New avenues of exploration for erythropoietin. JAMA 293: 90-95, 2005
117. Tillmann HC, Kuhn B, Kranzlin B, Sadick M, Gross J, Gretz N, Pill J: Efficacy and immunogenicity of novel erythropoietic agents and conventional rhEPO in rats with renal insufficiency. Kidney Int 69: 60-67, 2006
118. Heeschen C, Aicher A, Lehmann R, Fichtischerer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S: Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102: 1340-1346, 2003
119. Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell'Era P, Nico B, Roncali L, Dammacco F: Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93: 2627-2636, 1999
120. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M: Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A 87: 5978-5982, 1990
121. Bahlmann FH, DeGroot K, Duckert T, Niemczyk E, Bahlmann E, Boehm SM, Haller H, Fliser D: Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int 64: 1648-1652, 2003